b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30872149</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>25</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>14</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1097-6787</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>81</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Jul</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of the American Academy of Dermatology</Title>\n                <ISOAbbreviation>J. Am. Acad. Dermatol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>North American clinical management guidelines for hidradenitis suppurativa: A\xc2\xa0publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>91-101</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0190-9622(19)30368-8</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2019.02.068</ELocationID>\n            <Abstract>\n                <AbstractText>Hidradenitis suppurativa is a severe and debilitating dermatologic disease. Clinical management is challenging and consists of both medical and surgical approaches, which must often be combined for best outcomes. Therapeutic approaches have evolved rapidly in the last decade and include the use of topical therapies, systemic antibiotics, hormonal therapies, and a wide range of immunomodulating medications. An evidence-based guideline is presented to support\xc2\xa0health care practitioners as they select optimal medical management strategies and is reviewed in this second part of the management guidelines. A therapeutic algorithm informed by the evidence available at the time of the review is provided.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Alikhan</LastName>\n                    <ForeName>Ali</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sutter Health, Sacramento, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sayed</LastName>\n                    <ForeName>Christopher</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: christopher_sayed@med.unc.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Alavi</LastName>\n                    <ForeName>Afsaneh</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Alhusayen</LastName>\n                    <ForeName>Raed</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Brassard</LastName>\n                    <ForeName>Alain</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University of California at Davis, Sacramento, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Burkhart</LastName>\n                    <ForeName>Craig</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Crowell</LastName>\n                    <ForeName>Karen</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Health Sciences Library, University of North Carolina School of Medicine, Chapel Hill, North Carolina.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Eisen</LastName>\n                    <ForeName>Daniel B</ForeName>\n                    <Initials>DB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University of California at Davis, Sacramento, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gottlieb</LastName>\n                    <ForeName>Alice B</ForeName>\n                    <Initials>AB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Icahn School of Medicine at Mt Sinai Hospital, New York, New York.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hamzavi</LastName>\n                    <ForeName>Iltefat</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hazen</LastName>\n                    <ForeName>Paul G</ForeName>\n                    <Initials>PG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Associates in Dermatology, Westlake, Ohio.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jaleel</LastName>\n                    <ForeName>Tara</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Duke University School of Medicine, Durham, North Carolina.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kimball</LastName>\n                    <ForeName>Alexa B</ForeName>\n                    <Initials>AB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Harvard Medical School, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kirby</LastName>\n                    <ForeName>Joslyn</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lowes</LastName>\n                    <ForeName>Michelle A</ForeName>\n                    <Initials>MA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory for Investigative Dermatology, New York, New York.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Micheletti</LastName>\n                    <ForeName>Robert</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Miller</LastName>\n                    <ForeName>Angela</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Naik</LastName>\n                    <ForeName>Haley B</ForeName>\n                    <Initials>HB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University of California San Francisco, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Orgill</LastName>\n                    <ForeName>Dennis</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Plastic Surgery, Brigham and Women\'s Hospital, Boston, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Poulin</LastName>\n                    <ForeName>Yves</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Centre de Recherche Dermatologique du Quebec Metropolitain, Quebec City, Quebec, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>KL2 TR001870</GrantID>\n                    <Acronym>TR</Acronym>\n                    <Agency>NCATS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>11</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Am Acad Dermatol</MedlineTA>\n            <NlmUniqueID>7907132</NlmUniqueID>\n            <ISSNLinking>0190-9622</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000726">Androgen Antagonists</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000287" MajorTopicYN="N">Administration, Topical</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000726" MajorTopicYN="N">Androgen Antagonists</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017497" MajorTopicYN="N">Hidradenitis Suppurativa</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015552" MajorTopicYN="N">Injections, Intralesional</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009656" MajorTopicYN="N" Type="Geographic">North America</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011642" MajorTopicYN="N">Publications</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Nd:YAG</Keyword>\n            <Keyword MajorTopicYN="N">acne inversa</Keyword>\n            <Keyword MajorTopicYN="N">adalimumab</Keyword>\n            <Keyword MajorTopicYN="N">biomarkers</Keyword>\n            <Keyword MajorTopicYN="N">carbon dioxide laser</Keyword>\n            <Keyword MajorTopicYN="N">clindamycin</Keyword>\n            <Keyword MajorTopicYN="N">comorbidities</Keyword>\n            <Keyword MajorTopicYN="N">ertapenem</Keyword>\n            <Keyword MajorTopicYN="N">finasteride</Keyword>\n            <Keyword MajorTopicYN="N">guidelines</Keyword>\n            <Keyword MajorTopicYN="N">hidradenitis suppurativa</Keyword>\n            <Keyword MajorTopicYN="N">infliximab</Keyword>\n            <Keyword MajorTopicYN="N">laser</Keyword>\n            <Keyword MajorTopicYN="N">lifestyle modification</Keyword>\n            <Keyword MajorTopicYN="N">microbiome</Keyword>\n            <Keyword MajorTopicYN="N">oral contraceptive pills</Keyword>\n            <Keyword MajorTopicYN="N">rifampin</Keyword>\n            <Keyword MajorTopicYN="N">spironolactone</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30872149</ArticleId>\n            <ArticleId IdType="pii">S0190-9622(19)30368-8</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jaad.2019.02.068</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'